Malathy Iyer

MDR-TB treatment costs 235% one's income: Study

MUMBAI: Some forms of tuberculosis are so expensive to treat that an average Mumbai family could spend over half its annual income on a single patient.

Read More →

India: WHO's shorter treatment for multidrug-resistant TB, city may not gain

Mumbai, 13 May 2016: On Thursday , the World Health Organisation (WHO) gave its nod for an affordable drug combination that cuts down time needed to treat multi-drug resistant tuberculosis from 24 months to around nine months.

Read More →

India: 57% of TB patients given wrong drugs

MUMBAI: Here's why drug-resistant tuberculosis (TB) breeds freely in Mumbai: Patients don't get appropriate medication.

Read More →

India: Government drags feet on ‘effective’ anti-TB drug

MUMBAI: Bedaquiline, the first anti-tuberculosis drug manufactured after rifampicin almost 50 years ago, has been effective in five Indian patients, shows a new study by a city hospital. But it cannot be prescribed to other drug-resistant TB patients because the Indian government, unlike the West and the World Health Organization, has yet to approve its use.

Read More →

Indians booed at global meet for ‘genocide of TB patients’

"The Indian government continues to deny that there are drug stockouts. Innocent children are dying when people continue to say that there are no stockouts."

Read More →

India: Cure? Patients worse after govt's 6-drug TB therapy

MUMBAI: Shasikala Sawant (name changed), a 22-year-old government worker, lived for barely six months after being diagnosed with drug-resistant tuberculosis (DR-TB) in a clinic near her Vasai house.

Read More →

Page 1 of 1 · Total posts: 6